Role of polyphenolics in the management of rheumatoid arthritis through intracellular signaling pathways: a mechanistic review
- PMID: 40220198
- DOI: 10.1007/s10787-025-01731-z
Role of polyphenolics in the management of rheumatoid arthritis through intracellular signaling pathways: a mechanistic review
Abstract
Inflammation of the joints, bone erosion, and cartilage destruction are the main characteristics of rheumatoid arthritis (RA) which causes joint malfunction, structural distortion, and long-term impairment of function. According to various studies, RA affects 0.1-2.0% of people globally. It is unclear what causes RA, but multiple pathways have been associated with its pathophysiology. Non-steroidal anti-inflammatory drugs; NSAIDs (diclofenac, celecoxib, and ibuprofen), disease-modifying antirheumatic drugs; DMARDs (methotrexate, azathioprine, and cyclosporine), immunological compounds (rituximab, anakinra, and infliximab), and immune suppressants are the currently available options. However, they are associated with major side effects, like hypertension, hepatotoxicity, gastric ulcers, and kidney dysfunction which results in their limited use. To treat RA effectively, there is an urgent need for treatment options that offer minimal side effects. The dietary polyphenols have therapeutic effects on RA based on their antioxidant, apoptotic, anti-inflammatory, immunosuppressive, and immunomodulatory characteristics. At the molecular level, interleukin (IL)-6, mitogen-activated protein kinase (MAPK), tumor necrosis factor-alpha (TNF-alpha), interleukin 1b, c-Jun N-terminal kinase (JNK), and nuclear factor k light-chain-enhancer of activated B-cell (NF-kB) pathways play a critical role in modulation. Various polyphenolic compounds have been studied for their potential efficacy against RA, including genistein, resveratrol, carnosol, curcumin, epigallocatechin gallate, kaempferol, and hydroxyl tyrosol. However, it is noted that most of the studies are investigated on animal models of RA. The present review article discusses the underlying mechanisms that lead to RA and explores the promising role of polyphenols as potential therapeutic agents.
Keywords: Anti-inflammatory cytokine; Immunomodulation; Polyphenols; Pro-inflammatory; Rheumatoid arthritis.
© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Conflict of interest: Authors have no financial or other conflicts to disclose.
Similar articles
-
Exploring the role of polyphenols in rheumatoid arthritis.Crit Rev Food Sci Nutr. 2022;62(19):5372-5393. doi: 10.1080/10408398.2021.1924613. Epub 2021 May 17. Crit Rev Food Sci Nutr. 2022. PMID: 33998910 Review.
-
Fuhu Lijie Tang treats rheumatoid arthritis through multitarget therapy from autoantigen formation to bone destruction.Phytomedicine. 2025 Sep;145:157086. doi: 10.1016/j.phymed.2025.157086. Epub 2025 Jul 16. Phytomedicine. 2025. PMID: 40706389
-
Targeting myeloid differentiation protein 2 ameliorates rheumatoid arthritis by inhibiting inflammation and ferroptosis via MAPK and NF-κB signaling pathways.J Mol Med (Berl). 2025 Jul;103(7):821-836. doi: 10.1007/s00109-025-02555-8. Epub 2025 May 21. J Mol Med (Berl). 2025. PMID: 40397030
-
The Therapeutic Potential of Phytochemicals Unlocks New Avenues in the Management of Rheumatoid Arthritis.Int J Mol Sci. 2025 Jul 16;26(14):6813. doi: 10.3390/ijms26146813. Int J Mol Sci. 2025. PMID: 40725063 Free PMC article. Review.
-
Natural and synthetic potential drug leads for rheumatoid arthritis probing innovative target: mitochondrial dysfunction and NLRP3 inflammasome activation.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul;398(7):8295-8312. doi: 10.1007/s00210-025-03897-3. Epub 2025 Feb 28. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40019529 Review.
References
-
- Ahn S-C, Kim G-Y, Kim J-H, Baik S-W, Han M-K, Lee H-J, Moon D-O, Lee C-M, Kang J-H, Kim B-H (2004) Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-Κb. Biochem Biophys Res Commun 313:148–155 - PubMed - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous